Literature DB >> 21394554

Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings.

Ryogo Minamimoto1, Miyako Morooka, Kazuo Kubota, Kimiteru Ito, Yoko Masuda-Miyata, Takuya Mitsumoto, Risen Hirai, Osamu Okazaki, Michiaki Hiroe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21394554     DOI： 10.1007/s12350-011-9358-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  6 in total

1.  Primary cardiac non-Hodgkin's lymphoma diagnosed by transthoracic echocardiography.

Authors:  Suma H Konety; James E Wooldridge; Richard E Kerber
Journal:  Echocardiography       Date:  2006-02       Impact factor: 1.724

2.  Primary cardiac lymphoma evaluated with integration of PET/CT and contrast-enhanced CT.

Authors:  Hung-Yi Su; Han-Luen Huang; Chen-Ming Sun; Shaw-Ming Hou; Meng-Ling Chen
Journal:  Clin Nucl Med       Date:  2009-05       Impact factor: 7.794

3.  Heart in the heart: dual faced primary cardiac lymphoma on PET-CT.

Authors:  Jin-Man Cho; Il-Suk Sohn; You-Jung Yang
Journal:  Int J Cardiol       Date:  2009-01-07       Impact factor: 4.164

4.  PET/CT imaging in a case of cardiac liposarcoma.

Authors:  Miao Zhang; Biao Li; Xufeng Jiang
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

5.  Primary myocardial lymphoma demonstrated by Tl-201, Tc-99m sestamibi, and Ga-67 SPECT.

Authors:  S Kosuda; S Kusano; F Ohsuzu
Journal:  Clin Nucl Med       Date:  1998-07       Impact factor: 7.794

6.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544
  6 in total
  9 in total

1.  Imaging characteristics of cardiac dominant diffuse large B-cell lymphoma demonstrated with MDCT and PET/CT.

Authors:  Yasuka Kikuchi; Noriko Oyama-Manabe; Osamu Manabe; Masanao Naya; Yoichi M Ito; Kanako C Hatanaka; Hiroyuki Tsutsui; Satoshi Terae; Nagara Tamaki; Hiroki Shirato
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-08       Impact factor: 9.236

2.  18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake.

Authors:  Renata Christian Martins Felix; Clécio Maria Gouvea; Christiane Cigagna Wiefels Reis; Jacqueline Sampaio Dos Santos Miranda; Ligia Beatriz Chaves Espinoso Schtruk; Alexandre Siciliano Colafranceschi; Cláudio Tinoco Mesquita
Journal:  J Nucl Cardiol       Date:  2018-06-14       Impact factor: 5.952

Review 3.  PET Assessment of Immune Cell Activity and Therapeutic Monitoring Following Myocardial Infarction.

Authors:  James T Thackeray
Journal:  Curr Cardiol Rep       Date:  2018-03-06       Impact factor: 2.931

4.  Clinically relevant strategies for lowering cardiomyocyte glucose uptake for 18F-FDG imaging of myocardial inflammation in mice.

Authors:  James T Thackeray; Jens P Bankstahl; Yong Wang; Kai C Wollert; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11-12       Impact factor: 9.236

5.  Assessment of the diagnostic accuracy of 18F-FDG PET/CT in prosthetic infective endocarditis and cardiac implantable electronic device infection: comparison of different interpretation criteria.

Authors:  Ana Jiménez-Ballvé; María Jesús Pérez-Castejón; Roberto C Delgado-Bolton; Cristina Sánchez-Enrique; Isidre Vilacosta; David Vivas; Carmen Olmos; Manuel E Fuentes Ferrer; José L Carreras-Delgado
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-09-05       Impact factor: 9.236

6.  High-dose chemotherapy with autologous stem cell transplantation following systemic chemotherapy, prophylactic intrathecal methotrexate, and radiotherapy prevents relapse and improves the outcome of advanced stage primary testicular lymphoma even with cardiac involvement.

Authors:  Shin Lee; Takahiro Yamauchi; Keiichi Kinoshita; Shin Imamura; Kenichi Kamiya
Journal:  J Clin Exp Hematop       Date:  2017-09-06

Review 7.  Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT.

Authors:  Ryogo Minamimoto
Journal:  Jpn J Radiol       Date:  2021-01-31       Impact factor: 2.374

8.  Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis.

Authors:  Miyako Morooka; Masao Moroi; Kimiichi Uno; Kimiteru Ito; Jin Wu; Takashi Nakagawa; Kazuo Kubota; Ryogo Minamimoto; Yoko Miyata; Momoko Okasaki; Osamu Okazaki; Yoshihito Yamada; Tetsuo Yamaguchi; Michiaki Hiroe
Journal:  EJNMMI Res       Date:  2014-01-02       Impact factor: 3.138

9.  Tumor encasement of the right coronary artery: role of anatomic and functional imaging in diagnosis and therapeutic management.

Authors:  Yu-Hsiang Juan; Yiannis S Chatzizisis; Sachin S Saboo; Tatiana Rocha; Michael L Steigner
Journal:  Open Cardiovasc Med J       Date:  2014-11-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.